Loading…

BIOTRONIK received a group purchasing contract from Vizient, Inc. for its coronary products including the Orsiro drug-eluting stent, increasing access for Vizient members.
“BIOTRONIK today announced that it has received a group purchasing contract from Vizient, Inc., the largest, member-driven, healthcare performance improvement company in the United States.”prnewswire.com
Summarized from public sources; check the original articles before acting on it.